Li et al. reported that the PD-L1 expression in colorectal tumor cells and the PD-1 expression in tumor-infiltrating cells are associated with a favorable 5-year overall survival (OS) and disease-free survival (DFS) in patients with CRC [36]. This evidence concerns the gene RPL17 and colorectal neoplasm.